These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 1582055

  • 1. Lymphocyte release of soluble IL-2 receptors in patients with minimal change nephropathy.
    Mandreoli M, Beltrandi E, Casadei-Maldini M, Mancini R, Zucchelli A, Zucchelli P.
    Clin Nephrol; 1992 Apr; 37(4):177-82. PubMed ID: 1582055
    [Abstract] [Full Text] [Related]

  • 2. Depression of normal lymphocyte transformation by sera of patients with minimal change nephropathy and other forms of nephrotic syndrome.
    Taube D, Chapman S, Brown Z, Williams DG.
    Clin Nephrol; 1981 Jun; 15(6):286-90. PubMed ID: 7249426
    [Abstract] [Full Text] [Related]

  • 3. Soluble interleukin-2 receptors in sera of children with primary malignant neoplasms.
    Bodey B, Psenko V, Lipsey AL, Kaiser HE.
    Anticancer Res; 1996 Jun; 16(1):219-24. PubMed ID: 8615612
    [Abstract] [Full Text] [Related]

  • 4. Soluble interleukin 2 receptor levels in serum and its relationship to T cell abnormality and clinical manifestations of the disease in patients with systemic lupus erythematosus.
    Raziuddin S, al-Janadi MA, al-Wabel AA.
    J Rheumatol; 1991 Jun; 18(6):831-6. PubMed ID: 1680190
    [Abstract] [Full Text] [Related]

  • 5. Soluble interleukin 2 receptor (sIL-2R) levels in renal transplant recipients.
    Mehta R, Shah G, Adler W, Kittur D.
    Clin Transplant; 2004 Jun; 18 Suppl 12():67-71. PubMed ID: 15217411
    [Abstract] [Full Text] [Related]

  • 6. The in vitro effect on T cell function of soluble IL-2Ralpha from advanced ovarian cancer ascites.
    Elg SA, Hill RB, Heldman L, Ramakrishnan S.
    Gynecol Oncol; 1997 Jul; 66(1):133-7. PubMed ID: 9234933
    [Abstract] [Full Text] [Related]

  • 7. Soluble IL-2 receptor in patients with primary nephrotic syndrome.
    Ohno I, Gomi H, Matsuda H, Nakano H, Matsumoto H, Kodama K, Shibasaki T, Ishimoto F, Sakai O.
    Nihon Jinzo Gakkai Shi; 1991 May; 33(5):483-9. PubMed ID: 1895547
    [Abstract] [Full Text] [Related]

  • 8. Elevated serum levels of soluble interleukin-2 receptors in HIV infection: no correlation with activated T cells.
    Lang JM, Coumaros G, Levy S, Falkenrodt A, Steckmeyer M, Partisani M, Aleksijevic A, Lehr L, Koehl C.
    Nouv Rev Fr Hematol (1978); 1989 May; 31(1):9-11. PubMed ID: 2783774
    [Abstract] [Full Text] [Related]

  • 9. T-lymphocyte populations, cytokines and other growth factors in serum and urine of children with idiopathic nephrotic syndrome.
    Daniel V, Trautmann Y, Konrad M, Nayir A, Schärer K.
    Clin Nephrol; 1997 May; 47(5):289-97. PubMed ID: 9181275
    [Abstract] [Full Text] [Related]

  • 10. Constitutive secretion of soluble interleukin-2 receptor by human T cell lymphoma xenografted into SCID mice. Correlation of tumor volume with concentration of tumor-derived soluble interleukin-2 receptor in body fluids of the host mice.
    Wasik MA, Sioutos N, Tuttle M, Butmarc JR, Kaplan WD, Kadin ME.
    Am J Pathol; 1994 May; 144(5):1089-97. PubMed ID: 8178932
    [Abstract] [Full Text] [Related]

  • 11. Increased levels of soluble interleukin-2 receptor in veno-occlusive disease of the liver after allogenic bone marrow transplantation.
    Remberger M, Ringdén O.
    Transplantation; 1995 Dec 15; 60(11):1293-9. PubMed ID: 8525524
    [Abstract] [Full Text] [Related]

  • 12. A multicenter study to evaluate a novel assay for quantitation of soluble interleukin 2 receptor in renal transplant recipients.
    Schroeder TJ, Helling T, McKenna RM, Rush D, Jeffrey JR, Brewer B, Martin LA, Traylor D, Fisher RA, First MR.
    Transplantation; 1992 Jan 15; 53(1):34-40. PubMed ID: 1733082
    [Abstract] [Full Text] [Related]

  • 13. [Soluble interleukin 2 receptor (sIL-2R) in patients with esophageal carcinoma].
    Duan ZF.
    Zhonghua Zhong Liu Za Zhi; 1993 Jan 15; 15(1):17-9. PubMed ID: 8334935
    [Abstract] [Full Text] [Related]

  • 14. Effects of cyclosporine A on serum and urinary soluble interleukin-2 receptor in patients with lupus nephritis.
    Tang Z, Zhang J, Zhang S, Li L.
    Chin Med J (Engl); 1997 Sep 15; 110(9):686-9. PubMed ID: 9642325
    [Abstract] [Full Text] [Related]

  • 15. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
    Hildesheim A, Schiffman MH, Tsukui T, Swanson CA, Lucci J, Scott DR, Glass AG, Rush BB, Lorincz AT, Corrigan A, Burk RD, Helgesen K, Houghten RA, Sherman ME, Kurman RJ, Berzofsky JA, Kramer TR.
    Cancer Epidemiol Biomarkers Prev; 1997 Oct 15; 6(10):807-13. PubMed ID: 9332763
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.